AHR and pancreatic neoplasm: Furthermore, Jin et al. [149] have demonstrated that omeprazole, an H+/K+ ATP pump inhibitor of parietal cells of the gut, is able to decrease the expression of ALCAM in pancreatic cancer cells, an effect that appears to be attributable to its interaction with the aryl hydrocarbon receptor, AhR.